var measurecompliancedetailsdataSet = [
    [
        /*0 Meausure Category*/ "Measure",
        /*1 Measure Detail*/"Specific Measure Details",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
    [
        /*0 Meausure Category*/ "Asthma",
        /*1 Measure Detail*/"Inhaled corticosteroid	",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
    [
        /*0 Meausure Category*/ "CAD",
        /*1 Measure Detail*/"Details",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
    [
        /*0 Meausure Category*/ "CAD",
        /*1 Measure Detail*/"ACE or ARB",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
    [
        /*0 Meausure Category*/ "CAD",
        /*1 Measure Detail*/"ACE/ARB with diabetes	",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
    [
        /*0 Meausure Category*/ "CAD",
        /*1 Measure Detail*/"Antiplatelet therapy	",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
    [
        /*0 Meausure Category*/ "COPD",
        /*1 Measure Detail*/"Influenza immunization	",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
    [
        /*0 Meausure Category*/ "COPD",
        /*1 Measure Detail*/"Inhaled bronchodilator therapy	",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
    [
        /*0 Meausure Category*/ "COPD",
        /*1 Measure Detail*/"Pneumococcal vaccination or assessment	",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
    ],
        [
        /*0 Meausure Category*/ "COPD",
        /*1 Measure Detail*/"Spirometry testing",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
        ],
        [
        /*0 Meausure Category*/ "COPD",
        /*1 Measure Detail*/"Anticoagulant therapy for atrial fibrillation at discharge",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
        ],
        [
        /*0 Meausure Category*/ "CVA",
        /*1 Measure Detail*/"Spirometry testing",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
        ],
        [
        /*0 Meausure Category*/ "Depression",
        /*1 Measure Detail*/"Effective acute phase treatment",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
        ],
        [
        /*0 Meausure Category*/ "Depression",
        /*1 Measure Detail*/"Effective continuation phase treatment",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
        ],
        [
        /*0 Meausure Category*/ "Diabetes",
        /*1 Measure Detail*/"Annual lipid profile",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
        ],
        [
        /*0 Meausure Category*/ "Diabetes",
        /*1 Measure Detail*/"Blood pressure management",
        /*2 # PCP's*/"#####",
        /*3 Compliant Patients*/"400",
        /*4 Percent Compliant*/"38%",
        /*5 Non-Compliant patients*/"300",
        /*6 Percent Non-Compliant*/"38%",
        ],
];